Scedosporium apiospermum brain abscesses in a patient receiving ibrutinib and venetoclax
(2020)
Journal Article
An 80-year-old male, with relapsed mantle cell lymphoma was treated on a trial with the combination of the bruton tyrosine kinase (BTK) inhibitor, ibrutinib, and BH3-mimetic, venetoclax, and achieved complete remission by both Computerized Tomography... Read More about Scedosporium apiospermum brain abscesses in a patient receiving ibrutinib and venetoclax.